Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

So compounded semaglutide is sold in a vial with a separate syringe. Compounding drugs isn’t a new practice. But due to the soaring demand for these weight loss drugs ... by the time of ...

That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss ... by the time of publication.) The FDA also issued a ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide ... in weight in the REDEFINE 1 study over 68 weeks that fell short of Novo Nordisk's hope of a 25% loss.

All of their health readings over time were compared. Men and women with dementia had a significantly higher rate of weight loss, judged using BMI and waist circumference. The weight dropped off ...